Skip to content

An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01223040
Enrollment
30
Registered
2010-10-18
Start date
2010-08-31
Completion date
Unknown
Last updated
2012-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Brief summary

The purpose of this study is to evaluate the effect of acute and repeat dosing of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in a population of dry eye patients.

Interventions

Subjects will be dosed (bilaterally) in the office during each visit. Between visits 2 and 3, patients will dose 4 times per day for the 7 day period.

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must have history of mild-moderate dry eye with use of (or desire to use) eye drops in past 6 months

Exclusion criteria

* Patients cannot wear contact lenses within 1 week prior nor during the study, and cannot have a history of hypersensitivity to any component of Systane Balance.

Design outcomes

Primary

MeasureTime frame
Changes in video Ocular Protection Index 10 and 55 minutes following Systane Balance instillation at Days 1 and 7.8 days

Secondary

MeasureTime frame
Changes in blink pattern in subjects with mean Interblink Interval (IBI) < 3 seconds at Days 2 and 89 days
Fluorescein staining at Visits 1 & 3 on the Ora staining scale9 days
Ocular Symptomology at each visit9 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026